Hugh Martin, former CEO, Pacific Biosciences Bio and Contact Info
Listen (1:45) Key events for 2011
Listen (9:05) RS Sequencer and its advantages
Listen (9:04) Disadvantages
Listen (:54) What happened to the stock?
Listen (2:30) Mike Hunkapiller joins team
Listen (6:16) What makes a good CEO?
Listen (2:17) How do you keep good people?
Listen (5:54) Fighting cancer personally
Listen (2:42) Clinical sequencing
Listen (3:50) Company direction
Listen (3:27) CSO Eric Schadt moves to NY
As part of our series, Sequencing and Genomic Medicine, I interviewed Hugh Martin of PacBio at the end of 2011. Personally, Hugh made headlines in 09 when he went public with his diagnosis of multiple myeloma. Previously, he served as CEO of ONI Systems—a high-speed optical telecommunications company he founded in 1998 and took public in 2000 and sold to Ciena in 2002 for $1 billion. Mr Martin led PacBio through an IPO and the commercial launch of their much anticipated RS Sequencer. On Jan 6 of 2012 it was announced that Mike Hunkapiller would step in as the new CEO. We hope to bring Mike to the program soon.